DEXCOM INC (DXCM)
US2521311074 - Common Stock
Get insights into the top gainers and losers of Thursday's after-hours session.
Which stocks are moving after the closing bell on Thursday?
Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble
The company raised the lower bound of its sales guidance for the year.
Dexcom Reports First Quarter 2024 Financial Results
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Noteworthy Thursday Option Activity: HLT, SMCI, DXCM
First Week of December 20th Options Trading For DexCom (DXCM)
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
Disruptive Forces: 3 Game-changing Stocks Reshaping the Tech Landscape
This April, discover three game-changing tech stocks with disruptive technologies poised to future-proof your portfolio in 2024.
Snowflake Larger Than S&P 500 Component DexCom
First Week of DXCM May 31st Options Trading
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading.
3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments
DexCom Stock Sees IBD Stock Market Rating Sweetens Ups; Earns 83 RS Rating
The Relative Strength (RS) Rating for DexCom stock entered a new percentile Monday, with a rise from 80 to 83.
2 Growth Stocks to Buy Hand Over Fist in April
These healthcare companies' target markets substantially overlap.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
7 Nasdaq Stocks to Sell in April Before They Crash & Burn
The momentum in growth companies is likely to run out. Move on from these Nasdaq stocks to sell in April before it's too late.
Dexcom Publishes Annual Sustainability Report
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy’ List
The S&P 500’s current P/E ratio is 30% higher than a year ago, making it easier to find overvalued S&P 500 stocks to buy.
Market Cap Game Show: Andy Cross vs. Bill Mann
Join the "Rule Breaker Investing" fun.
May 10th Options Now Available For DexCom (DXCM)
Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good.
Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
DexCom Takes Over #166 Spot From Capital One Financial
Two Hot AI Stocks Lead S&P 500 Monday
Super Micro and Micron , two big winners in 2024, led the way Monday.
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.
Nasdaq 100 Movers: TTWO, MU
S&P 500 Movers: TTWO, MU
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
DexCom, Blackstone and Royal Caribbean head this list of five stocks.